跳至主要内容
临床试验/DRKS00026218
DRKS00026218已完成未知

Effect of syntocinone (active ingredient: oxytocin) on neuronal processing of alcohol stimuli - Target-OXY-MRI

Zentralinstitut für Seelische Gesundheit0 个研究点目标入组 24 人开始时间: 2021年9月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Age between 18 and 65 years; ability to give fully informed consent and to undergo functional magnetic resonance imaging; written informed consent; diagnosis of alcohol use disorder according to DSM-5 (min. 2 AUD criteria).

排除标准

  • Pregnancy or lactation; presence of severe heart disease or long QT syndrome; participants < 18 or > 65 years of age; psychosis or other severe psychiatric disorder; severe internistic and neurological comorbidities; use of psychotropic medication other than antidepressants from the group of serotonin reuptake inhibitors (SSRI) or mirtazapine and of pipamperone; Current drug abuse of amphetamines, opiates, benzodiazepines, and cocaine (urine drug screening); Contraindication to functional magnetic resonance imaging.

研究者

相似试验

Effect of syntocinone (active ingredient: oxytocin)... | 临床试验